Portal de Periódicos da CAPES

Essential thrombocythaemia in children

1999; Wiley; Volume: 107; Issue: 4 Linguagem: Inglês

10.1046/j.1365-2141.1999.01545.x

1365-2141

Yigal Dror, Victor S. Blanchette,

Eosinophilic Disorders and Syndromes

British Journal of HaematologyVolume 107, Issue 4 p. 691-698 Essential thrombocythaemia in children Yigal Dror, Yigal Dror Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, and University of Toronto, Toronto, Ontario, CanadaSearch for more papers by this authorVictor S. Blanchette, Victor S. Blanchette Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, and University of Toronto, Toronto, Ontario, CanadaSearch for more papers by this author Yigal Dror, Yigal Dror Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, and University of Toronto, Toronto, Ontario, CanadaSearch for more papers by this authorVictor S. Blanchette, Victor S. Blanchette Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, and University of Toronto, Toronto, Ontario, CanadaSearch for more papers by this author First published: 24 December 2001 https://doi.org/10.1046/j.1365-2141.1999.01545.xCitations: 36 Dr Yigal Dror, Division of Paediatric Haematology/Oncology, Chaim Sheba Medical Centre, Tel-Hashomer 52621, Israel. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Amato, D. & Freedman, M.H. (1984) Eleven-year follow-up of primary thrombocythemia in a child. Journal of Pediatrics, 104, 639. 10.1016/S0022-3476(84)80571-5 CASPubMedWeb of Science®Google Scholar 2 Anagrelide Study Group (1992) Anagrelide, a therapy for thrombocythemic states: experience in 577 patients. American Journal of Medicine, 92, 69–76.DOI: 10.1016/0002-9343(92)90017-6 10.1016/0002-9343(92)90017-6 PubMedWeb of Science®Google Scholar 3 Barbui, T., Buelli, M., Cortelazzo, S., Viero, P. & De Gaetano, G. (1987) Aspirin and risk of bleeding in patients with thrombocythemia. American Journal of Medicine, 83, 265–268. 10.1016/0002-9343(87)90696-6 CASPubMedWeb of Science®Google Scholar 4 Barbui, T., Cortelazzo, S., Viero, P., Bassan, R., Dini, E. & Semeraro, N. (1983) Thrombohaemorrhagic complication in 101 cases of myeloproliferative disorders: relationship to platelet number and function. European Journal of Cancer and Clinical Oncology, 19, 1593–1599. 10.1016/0277-5379(83)90091-3 PubMedWeb of Science®Google Scholar 5 Barnhart, M.I., Kim, T.H., Evatt, B.L., Ragab, A.H., Lui, V.K. & Lusher, J.M. (1980) Essential thrombocythemia in a child: platelet ultrastructure and function. American Journal of Hematology, 8, 87–107. 10.1002/ajh.2830080111 CASPubMedWeb of Science®Google Scholar 6 Berk, P.D., Goldberg, J.D., Silverstein, M.N., Weinfeld, A., Donovan, P.B., Ellis, J.T., Landaw, S.A., Laszlo, J., Najean, Y., Pisciota, A.V. & Wasserman, L.R. (1981) Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. New England Journal of Medicine, 304, 441–447. 10.1056/NEJM198102193040801 PubMedWeb of Science®Google Scholar 7 Beressi, A.H., Tefferi, A., Silverstein, M.N., Petitt, R.M. & Hoagland, H.C. (1995) Outcome analysis of 34 pregnancies in women with essential thrombocythemia. Archives of Internal Medicine, 155, 1217–1222. 10.1001/archinte.155.11.1217 PubMedWeb of Science®Google Scholar 8 Bucalossi, A., Marotta, G., Bigazzi, C., Galieni, P. & Dispensa, E. (1996) Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with thrombosis. American Journal of Hematology, 52, 14–20. 10.1002/(SICI)1096-8652(199605)52:1 3.0.CO;2-9 CASPubMedWeb of Science®Google Scholar 9 Case, D.C. (1984) Therapy of essential thrombocythemia with thiotepa and chlorambucil. Blood, 63, 51–54. PubMedWeb of Science®Google Scholar 10 Chintagumpala, M.M., Steuber, C.P., Mahoney, D.H., Ogden, A.K. & Fernbach, D.J. (1991) Essential thrombocythemia in a child: management with anagrelide. American Journal of Pediatric Hematology and Oncology, 13, 52–56. 10.1097/00043426-199121000-00013 CASPubMedWeb of Science®Google Scholar 11 Cohen, N., Almozlino-Sarafian, D., Weissgarten, J., Alon, I., Zaidenstein, R., Dishi, V., Rahimi-Levne, N., Fried, K. & Golik, A. (1997) Benign familial microcytic thrombocytosis with autosomal dominant transmission. Clinical Genetics, 52, 47–50. 10.1111/j.1399-0004.1997.tb02513.x PubMedWeb of Science®Google Scholar 12 Cohen-Solal, K., Villeval, J.L., Titeux, M., Lok, S., Vainchenker, W. & Wendling, F. (1996) Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis. Blood, 88, 2578–2584. CASPubMedWeb of Science®Google Scholar 13 Colombi, M., Radaelli, F., Zocchi, L. & Maiolo, A.T. (1991) Thrombotic and hemorrhagic complications in essential thrombocythemia: a retrospective study of 103 patients. Cancer, 67, 2926–2930. 10.1002/1097-0142(19910601)67:11 3.0.CO;2-3 PubMedWeb of Science®Google Scholar 14 Cortelazzo, S., Barbui, T., Bassan, R. & Dini, E. (1980) Abnormal aggregation and increased size of platelets in myeloproliferative disorders. Thrombosis and Haemostasis, 43, 127–130. CASPubMedWeb of Science®Google Scholar 15 Cortelazzo, S., Finazzi, G., Ruggeri, M., Vestri, O., Galli, M., Rodeghiero, F. & Barbui, T. (1995) Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. New England Journal of Medicine, 332, 1132–1136. 10.1056/NEJM199504273321704 PubMedWeb of Science®Google Scholar 16 Cortelazzo, S., Viero, P., Finazzi, G., Di'emilio, A., Rodeghiero, F. & Barbui, T. (1990) Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. Journal of Clinical Oncology, 8, 556–562. 10.1200/JCO.1990.8.3.556 CASPubMedWeb of Science®Google Scholar 17 Dror, Y., Gelman-Kohan, Z., Hagai, Z., Juster-Reichter, A., Nisani-Ben Cohen, R. & Mogilner, B. (1994) Aplasia cutis congenita, elevated alpha-fetoprotein, and a distinct amniotic fluid acethylcholinesterase electrophoretic band. American Journal of Perinatology, 11, 149–153. 10.1055/s-2007-994576 CASPubMedWeb of Science®Google Scholar 18 Dror, Y., Zipursky, A. & Blanchette, V.S. (1999) Essential thrombocythemia in children. Journal of Pediatric Hematology/Oncology, in press. Google Scholar 19 Eyster, M.E., Saletan, S.L., Rabellino, E.M., Karanas, A., McDonald, T.P., Locke, L.A. & Luderer, J.R. (1986) Familial essential thrombocythemia. American Journal of Medicine, 80, 497–502.DOI: 10.1016/0002-9343(86)90727-8 10.1016/0002-9343(86)90727-8 PubMedWeb of Science®Google Scholar 20 Falconer, J., Pineo, G., Blahey, W., Bowen, T., Docksteader, B. & Jadusingh, I. (1987) Essential thrombocythemia associated with recurrent abortions and fetal growth retardation. American Journal of Hematology, 25, 345–347. 10.1002/ajh.2830250316 PubMedWeb of Science®Google Scholar 21 Fenaux, P., Simon, M., Lai, J.L., Goudemand, J. & Bauters, F. (1990) Clinical course of essential thrombocythemia in 147 cases. Cancer, 66, 549–556. 10.1002/1097-0142(19900801)66:3 3.0.CO;2-6 PubMedWeb of Science®Google Scholar 22 Fernandez-Robles, E., Vermylen, C., Martiat, P., Ninane, J. & Cornu, G. (1990) Familial essential thrombocythemia. Pediatric Hematology/Oncology, 7, 373–376. 10.3109/08880019009033414 PubMedWeb of Science®Google Scholar 23 Fialkow, P.J., Faguet, G.B., Jacobson, R.J., Vaidya, K. & Murphy, S. (1981) Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood, 58, 916–919. PubMedWeb of Science®Google Scholar 24 Fickers, M. & Speck, B. (1974) Thrombocythaemia. Acta Haematologica, 51, 257–265. 10.1159/000208303 CASPubMedWeb of Science®Google Scholar 25 Fielder, P.J., Gurney, A.L., Stefanich, E., Marian, M., Moore, M.W., Carver-Moore, K. & De Sauvage, F.J. (1996) Regulation of thrombopoietin levels by c-mpl mediated binding to platelets. Blood, 87, 2154–2161. CASPubMedWeb of Science®Google Scholar 26 Florensa, L., Besses, C., Almarcha, J., Lafuente, R., Palou, L., Pedro, C., Sans-Sabrafen, J. & Woessner, S. (1989) Circulating erythroid and megakaryocytic progenitors in polycythaemia vera and essential thrombocythaemia. European Journal of Haematology, 43, 417–422. 10.1111/j.1600-0609.1989.tb00329.x PubMedWeb of Science®Google Scholar 27 Freedman, M.H., Olivares, R.S. & McClure, P.D. (1973) Primary thrombocythemia in a child. Journal of Pediatrics, 83, 163–167. 10.1016/S0022-3476(73)80338-5 CASPubMedWeb of Science®Google Scholar 28 Genderen, P.J.J. & Michiels, J.J. (1995) Hydroxyurea in essential thrombocythemia. New England Journal of Medicine, 333, 802–803.DOI: 10.1056/NEJM199509213331216 10.1056/NEJM199509213331216 PubMedWeb of Science®Google Scholar 29 Harrison, C.N., Gale, R.E., Machin, S.J. & Linch, D.C. (1999) A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications. Blood, 93, 417–424. 10.1182/blood.V93.2.417 CASPubMedWeb of Science®Google Scholar 30 Heath, H.W. & Pearson, H.A. (1989) Thrombocytosis in pediatric outpatients. Journal of Pediatrics, 114, 805–807. 10.1016/S0022-3476(89)80141-6 CASPubMedWeb of Science®Google Scholar 31 Hehlmann, R., Jahn, M., Baumann, B. & Kopcke, W. (1988) Essential thrombocythemia: clinical characteristics and course of 61 cases. Cancer, 61, 2487–2496. 10.1002/1097-0142(19880615)61:12 3.0.CO;2-T PubMedWeb of Science®Google Scholar 32 Hermann, J., Fuchs, D., Sauerbrey, A., Hempel, L. & Zintl, F. (1998) Successful treatment of essential thrombocythemia with anagrelide in a child. Medical and Pediatric Oncology, 30, 367–371.DOI: 10.1002/(SICI)1096-911X(199806)30:6 3.0.CO;2-F 10.1002/(SICI)1096-911X(199806)30:6 3.0.CO;2-F CASPubMedWeb of Science®Google Scholar 33 Hirayama, Y., Sakamaki, S., Matsunaga, T., Kuga, T., Kuroda, H., Kusakabe, T., Sasaki, K., Fujikawa, K., Kato, J., Kogawa, K., Koyama, R. & Niitsu, Y. (1998) Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cells. Blood, 92, 46–52. 10.1182/blood.V92.1.46.413k44_46_52 CASPubMedWeb of Science®Google Scholar 34 Hoagland, H.C. & Silverstein, M.N. (1978) Primary thrombocythemia in the young patient. Mayo Clinic Proceedings, 53, 578–580. PubMedWeb of Science®Google Scholar 35 Hoffman, R. & Wasserman, L.R. (1979) Natural history and management of polycythemia vera. Advances in Internal Medicine, 24, 255–285. PubMedGoogle Scholar 36 Horikawa, Y., Matsumura, I., Hashimoto, K., Shiraga, M., Kosugi, S., Tadokoro, S., Kato, T., Miyazaki, H., Tomiyama, Y., Kurata, Y., Matsuzawa, Y. & Kanakura, Y. (1997) Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia. Blood, 90, 4031–4038. 10.1182/blood.V90.10.4031 CASPubMedWeb of Science®Google Scholar 37 Host, N.B. & Saunamaki, K.I. (1992) Coronary heart disease in young age associated with essential thrombocythemia. American Heart Journal, 124, 219–221.DOI: 10.1016/0002-8703(92)90945-R 10.1016/0002-8703(92)90945-R CASPubMedWeb of Science®Google Scholar 38 Juvonen, E., Ikkala, E., Oksanen, K. & Ruutu, T. (1993) Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications. British Journal of Haematology, 83, 192–197. 10.1111/j.1365-2141.1993.tb08271.x PubMedWeb of Science®Google Scholar 39 Kaplan, M.E., Mack, K., Goldberg, J.D., Donovan, P.B., Berk, P.D. & Wasserman, L.R. (1987) Long-term management of polycythemia vera with hydroxyurea: a progress report. Seminars in Hematology, 23, 167–171. Web of Science®Google Scholar 40 Kapoor, G., Correa, H. & Yu, L.C. (1996) Essential thrombocythemia in an infant. Journal of Pediatric Hematology/Oncology, 18, 381–383.DOI: 10.1097/00043426-199611000-00009 10.1097/00043426-199611000-00009 CASPubMedWeb of Science®Google Scholar 41 Kessler, C.M., Klein, H.G. & Havlik, R.J. (1982) Uncontrolled thrombocytosis in chronic myeloproliferative disorders. British Journal of Haematology, 50, 157–167. 10.1111/j.1365-2141.1982.tb01900.x PubMedWeb of Science®Google Scholar 42 Kikawa, Y., Fukumoto, Y., Obata, K., Tamura, S., Takeuchi, M., Tanizawa, A. & Mayumi, M. (1998) Successful treatment of essential thrombocythemia evolving into agnogenic myeloid metaplasia with interferon-alpha. Journal of Pediatric Hematology/Oncology, 20, 463–466.DOI: 10.1097/00043426-199809000-00010 10.1097/00043426-199809000-00010 CASPubMedWeb of Science®Google Scholar 43 Kikuchi, M., Tayama, T., Hayakawa, H., Takahashi, I., Hoshino, H. & Ohsaka, A. (1995) Familial thrombocytosis. British Journal of Haematology, 89, 900–902. 10.1111/j.1365-2141.1995.tb08432.x PubMedWeb of Science®Google Scholar 44 Kiladjian, J.J., Elkassar, N., Hetet, G., Briere, J., Grandchamp, B. & Gardin, C. (1997) Study of the thrombopoietin receptor in essential thrombocythemia. Leukemia, 11, 1821–1826.DOI: 10.1038/sj.leu.2400845 10.1038/sj.leu.2400845 CASPubMedWeb of Science®Google Scholar 45 Kondo, T., Okabe, M., Sanada, M., Kurosawa, M., Suzuki, S., Kobayashi, M., Hosokawa, M. & Asaka, M. (1998) Familial essential thrombocythemia associated with one-base deletion in the 5′-untranslated region of the thrombopoietin gene. Blood, 92, 1091–1096. 10.1182/blood.V92.4.1091 CASPubMedWeb of Science®Google Scholar 46 Kunishima, S., Mizuno, S., Naoe, T., Saito, H. & Kamiya, T. (1998) Genes for thrombopoietin and c-mpl are not responsible for familial thrombocythaemia: a case study. British Journal of Haematology, 100, 383–386.DOI: 10.1046/j.1365-2141.1998.00571.x 10.1046/j.1365-2141.1998.00571.x CASPubMedWeb of Science®Google Scholar 47 Lackner, H., Urban, C., Beham-Schmid, C., Benesch, M., Kerbl, R. & Schwinger, W. (1998) Treatment of children with anagrelide for thrombocythemia. Journal of Pediatric Hematology/Oncology, 20, 469–473.DOI: 10.1097/00043426-199809000-00012 10.1097/00043426-199809000-00012 CASPubMedWeb of Science®Google Scholar 48 Lahuerta-Palacios, J.J., Borstein, R., Fernandez-Debora, F.J., Gutierrez-Rivas, E., Ortis, M.C., Larregla, S., Calandre, L. & Montero-Castillo, J. (1988) Controlled and uncontrolled thrombocytosis: its clinical role in essential thrombocythemia. Cancer, 61, 1207–1212. 10.1002/1097-0142(19880315)61:6 3.0.CO;2-4 PubMedWeb of Science®Google Scholar 49 Linch, D.C., Hutton, R., Cowan, D., Moore, A.R., Richards, J.D.M. & Wilkinson, L.S. (1982) Primary thrombocythaemia in childhood. Scandinavian Journal of Haematology, 28, 72–76. 10.1111/j.1600-0609.1982.tb02123.x CASPubMedWeb of Science®Google Scholar 50 Lumley, S.E. (1971) Essential thrombocythaemia in childhood. Proceedings of the Royal Society of Medicine, 64, 22–23. CASPubMedWeb of Science®Google Scholar 51 McIntyre, K.J., Hoagland, H.C., Silverstein, M.N. & Petitt, R.M. (1991) Essential thrombocythemia in young adults. Mayo Clinic Proceedings, 66, 149–154. 10.1016/S0025-6196(12)60486-8 PubMedWeb of Science®Google Scholar 52 Mercer, B., Drouin, J., Jolly, E. & D'anjou, G. (1988) Primary thrombocythemia in pregnancy: a report of two cases. American Journal of Obstetetrics and Gynecology, 159, 127–128. 10.1016/0002-9378(88)90507-8 PubMedWeb of Science®Google Scholar 53 Mertens, F., Johansson, B., Heim, S., Kristoffersson, U. & Mitelman, F. (1991) Karyotypic patterns in chronic myeloproliferative disorders: report on 74 cases and review of the literature. Leukemia, 5, 214–220. PubMedWeb of Science®Google Scholar 54 Michiels, J.J. & Van Genderen, P.J. (1997) Essential thrombocythemia in childhood. Seminars in Thrombosis and Hemostasis, 23, 295–301. 10.1055/s-2007-996102 CASPubMedWeb of Science®Google Scholar 55 Mitus, A.J., Barbui, T., Shulman, L.N., Rosenthal, D.S., Viero, P., Cortelazzo, S. & Schaffer, A.I. (1990) Hemostatic complications in young patients with essential thrombocythemia. American Journal of Medicine, 88, 371–375.DOI: 10.1016/0002-9343(90)90491-U 10.1016/0002-9343(90)90491-U PubMedWeb of Science®Google Scholar 56 Mughal, T.I. (1995) Primary thrombocythemia: a current prospective. Stem Cell, 13, 355–359. 10.1002/stem.5530130406 CASPubMedWeb of Science®Google Scholar 57 Murphy, S., Peterson, P., Iland, H. & Laszlo, J. (1997) Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment. Seminars in Hematology, 34, 29–39. PubMedWeb of Science®Google Scholar 58 Nand, S., Stock, W., Godwin, J. & Fisher, S.G. (1996) Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia and myeloid metaplasia with myelofibrosis. American Journal of Hematology, 52, 42–46.DOI: 10.1002/(SICI)1096-8652(199605)52:1 3.0.CO;2-6 10.1002/(SICI)1096-8652(199605)52:1 3.0.CO;2-6 CASPubMedWeb of Science®Google Scholar 59 Ozer, F.L., Wayne, E.T., Miech, D.C. & Levin, W.C. (1960) Primary hemorrhagic thrombocythemia. American Journal of Medicine, 28, 807–823.DOI: 10.1016/0002-9343(60)90136-4 10.1016/0002-9343(60)90136-4 CASPubMedWeb of Science®Google Scholar 60 Pogliani, E.M., Rossini, F., Miccolis, I., Ferrario, A., Perego, D., Casaroli, I., Bolis, S., Fagnani, D., Brabilla, M. & Corneo, G. (1995) Alpha-interferon as initial treatment of essential thrombocythemia: analysis after two years of follow-up. Tumori, 81, 245–248. 10.1177/030089169508100406 CASPubMedWeb of Science®Google Scholar 61 Sceats, D.J. & Baitlon, D. (1980) Primary thrombocythemia in a child. Clinical Pediatrics, 19, 298–300. 10.1177/000992288001900417 CASPubMedWeb of Science®Google Scholar 62 Schlemper, R.J., Van Der Maas, A.P.C. & Eikenboom, J.C.J. (1994) Familial essential thrombocythemia: clinical characteristics of 11 cases in one family. Annals of Hematology, 68, 153–158. 10.1007/BF01727421 PubMedWeb of Science®Google Scholar 63 Sedlaceck, S.M., Curtis, J.L., Weintraub, J. & Levin, J. (1986) Essential thrombocythemia and leukemic transformation. Medicine, 65, 353–364. PubMedWeb of Science®Google Scholar 64 Seewan, H.L., Zikulnig, R. & Gallhofer, G. (1991) Treatment of thrombocytosis in chronic myeloproliferative disorders with interferon alfa-2b. European Journal of Cancer, 27, (Suppl.), 58–68. 10.1016/0277-5379(91)90576-Y PubMedWeb of Science®Google Scholar 65 Silverstein, M.N., Petitt, R.M., Solberg, L.A., Jr, Fleming, J.S., Knight, R.C. & Schacter, L.P. (1988) Anagrelide: a new drug for treating thrombocytosis. New England Journal of Medicine, 318, 1291–1294. 10.1056/NEJM198805193182002 Web of Science®Google Scholar 66 Slee, P.H., Van Everdingen, J.J.E., Geraedts, J.P.M., Velde, J. & Den Ottolander, G.J. (1981) Familial myeloproliferative disease: hematological and cytogenetic studies. Acta Medica Scandinavica, 210, 321–327. 10.1111/j.0954-6820.1981.tb09824.x PubMedWeb of Science®Google Scholar 67 Snethlage, W. & Ten Cate, J.W. (1986) Thrombocythaemia and recurrent late abortions: normal outcome of pregnancies after antiaggregatory treatment: case report. British Journal of Obstetrics and Gynaecology, 93, 386–388. PubMedWeb of Science®Google Scholar 68 Spach, M.S., Howell, D.A. & Harris, J.S. (1963) Myocardial infarction and multiple thromboses in a child with primary thrombocytosis. Pediatrics, 31, 268–276. PubMedWeb of Science®Google Scholar 69 Spencer, C.M. & Brogden, R.N. (1994) Anagrelide: a review of its pharmacodynamic properties and therapeutic potential in the treatment of thrombocythemia. Drugs, 47, 809–822. 10.2165/00003495-199447050-00007 CASPubMedWeb of Science®Google Scholar 70 Sterkers, Y., Preudhomme, C., Lai, J.L., Demory, J.L., Caulier, J.L., Wattel, E., Bordessoule, D., Bauters, F. & Fenaux, P. (1998) Acute myeloid leukemia and myelodysplastic syndrome following essential thrombocythaemia, treated with hydroxyurea: high proportion of cases with 17p deletion. Blood, 91, 616–622. CASPubMedWeb of Science®Google Scholar 71 Taksin, A.L., Couedic, J.P.L., Dusanter-Fourt, I., Masse, A., Giraudier, S., Katz, A., Wendling, F., Vainchenker, W., Casadevall, N. & Debili, N. (1999) Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by mpl-L. Blood, 93, 125–139. CASPubMedWeb of Science®Google Scholar 72 Tartaglia, A.P., Goldberg, J.D., Berk, P.D. & Wasserman, L.R. (1986) Adverse effect of antiaggregating platelet therapy in the treatment of polycythemia vera. Seminars in Hematology, 23, 172–176. PubMedWeb of Science®Google Scholar 73 Tefferi, A. & Hoagland, H.C. (1994) Issues in the diagnosis and management of essential thrombocythemia. Mayo Clinic Proceedings, 69, 651–655. 10.1016/S0025-6196(12)61342-1 PubMedWeb of Science®Google Scholar 74 Thornley, S. & Manoharan, A. (1994) Successful treatment of essential thrombocythemia with alpha interferon during pregnancy. European Journal of Haematology, 52, 63–64. 10.1111/j.1600-0609.1994.tb01287.x CASPubMedWeb of Science®Google Scholar 75 Van Dijken, P.J., Woldendrop, K.H. & Van Wouwe, J.P. (1996) Familial thrombocytosis in infancy presenting with leukemoid reaction. Acta Paediatrica, 85, 1132–1134. 10.1111/j.1651-2227.1996.tb14234.x PubMedWeb of Science®Google Scholar 76 Vora, A.J. & Lilleyman, J.S. (1993) Secondary thrombocytosis. Archives of Diseases of Childhood, 68, 88–90. 10.1136/adc.68.1.88 PubMedWeb of Science®Google Scholar 77 Watanabe, K., Takeuuchi, K., Kawai, Y., Ikeda, F., Kubota, F. & Nakamoto, H. (1995) Automated measurement of reticulated platelets in estimating thrombopoiesis. European Journal of Haematology, 54, 163–171. 10.1111/j.1600-0609.1995.tb00209.x PubMedWeb of Science®Google Scholar 78 Weinfeld, A., Swolin, B. & Westin, J. (1994) Acute leukemia after hydroxyurea therapy in polycythemia vera and allied disorders: prospective study of efficacy and leukemogenicity with therapeutic implications. European Journal of Haematology, 52, 134–139. 10.1111/j.1600-0609.1994.tb01303.x CASPubMedWeb of Science®Google Scholar 79 Wiestner, A., Schlemper, R.J., Van Der Maas, A.P. & Skoda, R.C. (1998) An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nature Genetics, 18, 49–52.DOI: 10.1038/ng0198-49 10.1038/ng0198-49 CASPubMedWeb of Science®Google Scholar 80 Williams, E.C. & Shahidi, N.T. (1991) Benign familial thrombocytosis. American Journal of Hematology, 37, 124–125. 10.1002/ajh.2830370211 PubMedWeb of Science®Google Scholar 81 Zaccaria, A. & Tura, S. (1978) A chromosomal abnormality in primary thrombocythemia. New England Journal of Medicine, 298, 1422–1423. 10.1056/NEJM197806222982514 CASPubMedWeb of Science®Google Scholar 82 Yoshida, N., Ishii, E., Koga, N., Kamimura, T. & Miyazaki, S. (1998) Analysis of thrombopoietin and c-mpl expression in a child with essential thrombocythemia. Pediatric Hematology/Oncology, 15, 359–363. 10.3109/08880019809014021 Web of Science®Google Scholar Citing Literature Volume107, Issue4December 1999Pages 691-698 ReferencesRelatedInformation